GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MEDITERA TIBBI MALZEME SANAYI VE TICARET AS (IST:MEDTR) » Definitions » 5-Year Yield-on-Cost %

MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) 5-Year Yield-on-Cost % : 0.61 (As of Dec. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is MEDITERA TIBBI MALZEMENAYI VE TICARET AS 5-Year Yield-on-Cost %?

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's yield on cost for the quarter that ended in Sep. 2024 was 0.61.


The historical rank and industry rank for MEDITERA TIBBI MALZEMENAYI VE TICARET AS's 5-Year Yield-on-Cost % or its related term are showing as below:

IST:MEDTR' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.57   Med: 3.4   Max: 9.71
Current: 0.61


During the past 6 years, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's highest Yield on Cost was 9.71. The lowest was 0.57. And the median was 3.40.


IST:MEDTR's 5-Year Yield-on-Cost % is ranked worse than
85.49% of 317 companies
in the Medical Devices & Instruments industry
Industry Median: 2.03 vs IST:MEDTR: 0.61

Competitive Comparison of MEDITERA TIBBI MALZEMENAYI VE TICARET AS's 5-Year Yield-on-Cost %

For the Medical Devices subindustry, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where MEDITERA TIBBI MALZEMENAYI VE TICARET AS's 5-Year Yield-on-Cost % falls into.



MEDITERA TIBBI MALZEMENAYI VE TICARET AS 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of MEDITERA TIBBI MALZEMENAYI VE TICARET AS is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

MEDITERA TIBBI MALZEMENAYI VE TICARET AS  (IST:MEDTR) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of MEDITERA TIBBI MALZEMENAYI VE TICARET AS's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS Business Description

Traded in Other Exchanges
N/A
Address
Sokak No: 29 Tire Organize Sanayi, Ibni Melek OSB Mahallesi, TOSBI Yol 4, Bolgesi Tire, Izmir, TUR, 35900
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is engaged in the manufacture of anesthesia and intensive care circuits, the installation, operation, and design of oncology drug preparation and delivery systems, production, sales, and technical service of infusion pumps and sets, and the manufacture of biocidal products.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Headlines

No Headlines